{"title":"Publishing clinical trial results: the future beckons.","authors":"Elizabeth Wager","doi":"10.1371/journal.pctr.0010031","DOIUrl":null,"url":null,"abstract":"Elizabeth WagerSearch for the truth is the noblestoccupation of man; its publication is aduty. —Madame de Stael (1766–1817)Formats for reporting results fromrandomized clinical trials in peer-re-viewed journals have remained virtuallyunchanged and unchallenged for thepast 50 years [1]. However, a number ofdevelopments, some technological andsome political, provide exciting oppor-tunities to question whether we areusing the most efficient and effectivemethods of publication. Here, I suggesthow methods of reporting clinical trialscould be improved and consider theimplications for trial sponsors andmedical journals.","PeriodicalId":87416,"journal":{"name":"PLoS clinical trials","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2006-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1371/journal.pctr.0010031","citationCount":"21","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1371/journal.pctr.0010031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 21
Abstract
Elizabeth WagerSearch for the truth is the noblestoccupation of man; its publication is aduty. —Madame de Stael (1766–1817)Formats for reporting results fromrandomized clinical trials in peer-re-viewed journals have remained virtuallyunchanged and unchallenged for thepast 50 years [1]. However, a number ofdevelopments, some technological andsome political, provide exciting oppor-tunities to question whether we areusing the most efficient and effectivemethods of publication. Here, I suggesthow methods of reporting clinical trialscould be improved and consider theimplications for trial sponsors andmedical journals.